Xylem (XYL)
(Delayed Data from NYSE)
$132.40 USD
+1.79 (1.37%)
Updated Apr 26, 2024 04:00 PM ET
After-Market: $132.41 +0.01 (0.01%) 7:58 PM ET
3-Hold of 5 3
D Value B Growth B Momentum C VGM
Xylem (XYL) Price Targets
Average Price Target | Highest Price Target | Lowest Price Target | Upside to Average Price Target |
---|---|---|---|
$136.64 | $150.00 | $110.00 | 4.62% |
Price Target
Based on short-term price targets offered by 14 analysts, the average price target for Xylem comes to $136.64. The forecasts range from a low of $110.00 to a high of $150.00. The average price target represents an increase of 4.62% from the last closing price of $130.61.
Analyst Price Targets (14)
Broker Rating
Xylem currently has an average brokerage recommendation (ABR) of 1.76 on a scale of 1 to 5 (Strong Buy to Strong Sell), calculated based on the actual recommendations (Buy, Hold, Sell etc.) made by 17 brokerage firms. The current ABR compares to an ABR of 1.81 a month ago based on 16 recommendations.
Of the 17 recommendations deriving the current ABR, 10 are Strong Buy and one is Buy. Strong Buy and Buy respectively account for 58.82% and 5.88% of all recommendations. A month ago, Strong Buy made up 56.25%, while Buy represented 6.25%.
Broker Rating Breakdown
Brokerage Recommendations
Today | 1 Week Ago | 1 Month Ago | 2 Months Ago | 3 Months Ago | |
---|---|---|---|---|---|
Strong Buy | 10 | 10 | 9 | 8 | 8 |
Buy | 1 | 1 | 1 | 1 | 1 |
Hold | 6 | 6 | 6 | 6 | 6 |
Sell | 0 | 0 | 0 | 0 | 0 |
Strong Sell | 0 | 0 | 0 | 0 | 0 |
ABR | 1.76 | 1.76 | 1.81 | 1.87 | 1.87 |
1. Not Ident. Many of the brokerage firms who provide Zacks data ask that we keep their identity confidential.
2. In most cases the # of brokers listed above is less than the # of brokerage firms that have a recommendation on the stock. That is because some firms prohibit Zacks from displaying detailed information on their recommendations such as in the upgrade/downgrade table.
Analyst Upgrades/Downgrades
Date | Brokerage Firm | Analyst | Previous | Current |
---|---|---|---|---|
3/27/2024 | Northcoast Research | Ryan M Connors | Hold | Hold |
3/21/2024 | Robert W. Baird & Co. | Michael P Halloran | Strong Buy | Strong Buy |
3/12/2024 | Exane BNP Paribas | Andrew E Buscaglia | Not Available | Strong Buy |
1/4/2024 | Raymond James | Pavel S Molchanov | Strong Sell | Hold |
1/2/2024 | Mizuho SecuritiesUSA | Brett Linzey | Not Available | Hold |
10/2/2023 | Not Identified | Not Identified | Not Available | Strong Buy |
8/29/2023 | Seaport Research Partners | Scott Graham | Not Available | Hold |
1. Not Ident. Many of the brokerage firms who provide Zacks data ask that we keep their identity confidential.
2. In most cases the # of brokers listed above is less than the # of brokerage firms that have a recommendation on the stock. That is because some firms prohibit Zacks from displaying detailed information on their recommendations such as in the upgrade/downgrade table.
Average Brokerage Rating
Current ABR | 1.76 |
ABR (Last week) | 1.76 |
# of Recs in ABR | 17 |
Average Target Price | $136.64 |
LT Growth Rate | 12.10% |
Industry | Manufacturing - General Industrial |
Industry Rank by ABR | 65 of 252 |
Current Quarter EPS Est: | 0.84 |